Welcome to Dividend.com
Please help us personalize your experience.
Select the one that best describes you
Continue to site >
Trending ETFs

BlackRock Health Sciences Opportunities Portfolio

mutual fund
BHSRX
Dividend policy
Suspended
Price as of:
$70.18 -1.22 0%
primary theme
Health Care Sector Equity
BHSRX (Mutual Fund)

BlackRock Health Sciences Opportunities Portfolio

Dividend policy
Suspended
Price as of:
$70.18 -1.22 0%
primary theme
Health Care Sector Equity
BHSRX (Mutual Fund)
BlackRock Health Sciences Opportunities Portfolio
Dividend policy
Suspended
Price as of:
$70.18 -1.22 0%
primary theme
Health Care Sector Equity

BHSRX - Snapshot

Vitals

  • YTD Return -2.5%
  • 3 Yr Annualized Return 15.5%
  • 5 Yr Annualized Return 15.9%
  • Net Assets $10.4 B
  • Holdings in Top 10 37.9%

52 WEEK LOW AND HIGH

$71.40
$46.99
$75.06

Expenses

OPERATING RELATED FEES

  • Expense Ratio 1.45%

SALES FEES

  • Front Load N/A
  • Deferred Load N/A

BROKERAGE FEES

  • Turnover 28.00%

TRADING FEES

  • Max Redemption Fee N/A

Min Investment

  • Standard (Taxable) $100
  • IRA N/A

Fund Classification

  • Primary Theme Health Care Sector Equity
  • Fund Type Open End Mutual Fund
  • Investment Style Health

Compare BHSRX to Popular Health Care Sector Equity Funds

Overview

Next Dividend

Income Profile

Income Risk

Returns Profile

Allocations

Expenses

About

Dividend.com Ratings*

$109.18

-1.79%

$16.03 B

1.22%

$1.36

blocked
blocked
blocked

-2.44%

0.10%

Compare BHSRX to Popular Health Care Sector Equity ETFs

Overview

Next Dividend

Income Profile

Income Risk

Returns Profile

Allocations

Expenses

About

Dividend.com Ratings*

$112.31

-1.27%

$24.05 B

1.49%

$1.69

blocked
blocked
blocked

-2.33%

0.13%

$222.30

-1.95%

$16.03 B

1.20%

$2.71

blocked
blocked
blocked

-2.47%

0.10%

$150.77

-3.58%

$10.74 B

0.20%

$0.31

blocked
blocked
blocked

-2.87%

0.46%

$326.43

-2.31%

$8.66 B

0.24%

$0.81

blocked
blocked
blocked

-2.74%

0.42%

$139.94

-4.71%

$7.85 B

0.19%

$0.28

blocked
blocked
blocked

-3.80%

0.35%

BHSRX - Profile

Distributions

  • YTD Total Return -2.5%
  • 3 Yr Annualized Total Return 15.5%
  • 5 Yr Annualized Total Return 15.9%
  • Capital Gain Distribution Frequency Annually
  • Net Income Ratio -0.32%
DIVIDENDS
  • Dividend Yield 0.0%
  • Dividend Distribution Frequency Annually

Fund Details

  • Legal Name
    BlackRock Health Sciences Opportunities Portfolio
  • Fund Family Name
    BlackRock
  • Inception Date
    Sep 12, 2011
  • Shares Outstanding
    N/A
  • Share Class
    Retirement
  • Currency
    USD
  • Domiciled Country
    United States
  • Manager
    Erin Xie

Fund Description

The fund invests at least 80% of its total assets in equity securities, primarily common stock, of companies in health sciences and related industries. The health sciences sector can include companies in health care equipment and supplies, health care providers and services, biotechnology, and pharmaceuticals. It will concentrate its investments (i.e., invest more than 25% of its assets) in health sciences or related industries, and may invest in companies located in non-U.S. countries.


BHSRX - Performance

Return Ranking - Trailing

Period BHSRX Return Category Return Low Category Return High Rank in Category (%)
YTD -2.5% -8.7% 16.9% 50.00%
1 Yr 25.7% 11.4% 174.0% 71.95%
3 Yr 15.5%* 3.7% 54.2% 37.06%
5 Yr 15.9%* 5.3% 44.0% 42.14%
10 Yr 16.1%* 9.3% 22.0% 48.39%

* Annualized

Return Ranking - Calendar

Period BHSRX Return Category Return Low Category Return High Rank in Category (%)
2020 14.2% -13.6% 178.2% 50.31%
2019 20.2% 3.8% 63.8% 54.48%
2018 -0.2% -49.7% 21.5% 21.90%
2017 20.0% -59.8% 54.4% 45.93%
2016 -8.6% -36.6% 11.6% 23.26%

Total Return Ranking - Trailing

Period BHSRX Return Category Return Low Category Return High Rank in Category (%)
YTD -2.5% -6.8% 16.9% 59.88%
1 Yr 25.7% 5.6% 174.0% 68.90%
3 Yr 15.5%* 2.6% 54.2% 32.87%
5 Yr 15.9%* 4.8% 44.0% 38.57%
10 Yr 16.1%* 9.3% 22.0% 46.77%

* Annualized

Total Return Ranking - Calendar

Period BHSRX Return Category Return Low Category Return High Rank in Category (%)
2020 14.2% -13.6% 178.2% 50.31%
2019 20.2% 3.8% 63.8% 54.48%
2018 -0.2% -25.3% 22.2% 29.20%
2017 24.3% -10.8% 54.4% 27.41%
2016 -6.4% -36.6% 11.6% 19.38%

NAV & Total Return History


BHSRX - Holdings

Concentration Analysis

BHSRX Category Low Category High BHSRX % Rank
Net Assets 10.4 B 6.18 M 49.1 B 8.67%
Number of Holdings 158 25 452 14.45%
Net Assets in Top 10 4.02 B 1.55 M 19.6 B 10.40%
Weighting of Top 10 37.86% 11.9% 77.2% 61.27%

Top 10 Holdings

  1. UnitedHealth Group Inc 7.39%
  2. Abbott Laboratories 5.43%
  3. Johnson & Johnson 4.49%
  4. Eli Lilly and Co 3.71%
  5. Thermo Fisher Scientific Inc 3.53%
  6. Cigna Corp 2.96%
  7. Amgen Inc 2.76%
  8. Medtronic PLC 2.67%
  9. Stryker Corp 2.63%
  10. Edwards Lifesciences Corp 2.62%

Asset Allocation

Weighting Return Low Return High BHSRX % Rank
Stocks
98.56% 82.92% 104.32% 57.80%
Other
1.69% -27.80% 10.48% 16.18%
Preferred Stocks
0.00% 0.00% 5.23% 96.53%
Convertible Bonds
0.00% 0.00% 0.02% 96.53%
Bonds
0.00% 0.00% 19.34% 96.53%
Cash
-0.24% -0.24% 11.60% 100.00%

Stock Sector Breakdown

Weighting Return Low Return High BHSRX % Rank
Healthcare
98.53% 63.91% 100.00% 68.79%
Financial Services
0.77% 0.00% 4.05% 17.92%
Basic Materials
0.69% 0.00% 3.50% 20.23%
Utilities
0.00% 0.00% 0.03% 96.53%
Technology
0.00% 0.00% 16.33% 98.84%
Real Estate
0.00% 0.00% 5.95% 97.11%
Industrials
0.00% 0.00% 4.84% 97.11%
Energy
0.00% 0.00% 0.03% 96.53%
Communication Services
0.00% 0.00% 13.83% 98.84%
Consumer Defense
0.00% 0.00% 30.57% 96.53%
Consumer Cyclical
0.00% 0.00% 11.81% 96.53%

Stock Geographic Breakdown

Weighting Return Low Return High BHSRX % Rank
US
88.47% 58.03% 100.01% 29.48%
Non US
10.09% 0.00% 40.57% 72.25%

BHSRX - Expenses

Operational Fees

BHSRX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Expense Ratio 1.45% 0.08% 25.14% 34.52%
Management Fee 0.67% 0.00% 1.25% 56.65%
12b-1 Fee 0.50% 0.00% 1.00% 68.42%
Administrative Fee N/A 0.03% 0.25% 25.00%

Sales Fees

BHSRX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Front Load N/A 3.50% 5.75% N/A
Deferred Load N/A 1.00% 5.00% N/A

Trading Fees

BHSRX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Max Redemption Fee N/A 1.00% 2.00% N/A

Related Fees

Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.

BHSRX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Turnover 28.00% 0.70% 252.00% 26.22%

BHSRX - Distributions

Dividend Yield Analysis

BHSRX Category Low Category High BHSRX % Rank
Dividend Yield 0.00% 0.00% 1.09% 96.53%

Dividend Distribution Analysis

BHSRX Category Low Category High Category Mod
Dividend Distribution Frequency Annually Annually Semi-Annually Annually

Net Income Ratio Analysis

BHSRX Category Low Category High BHSRX % Rank
Net Income Ratio -0.32% -2.53% 1.74% 71.60%

Capital Gain Distribution Analysis

BHSRX Category Low Category High Capital Mode
Capital Gain Distribution Frequency Annually Annually Semi-Annually Annually

Dividend Payout History

View More +

BHSRX - Fund Manager Analysis

Managers

Erin Xie


Start Date

Tenure

Tenure Rank

Jul 31, 2003

17.59

17.6%

Ms. Xie is the managing director and Portfolio Manager of BlackRock Advisor since 2006. Before becoming part of BlackRock Advisors in 2005, she was with State Street Research & Management since 2001. Ms. Xie began her investment career as a pharmaceutical analyst for Sanford Bernstein in 1999.

Xiang Liu


Start Date

Tenure

Tenure Rank

Jun 01, 2020

0.75

0.8%

Jeff Lee


Start Date

Tenure

Tenure Rank

Jun 01, 2020

0.75

0.8%

Tenure Analysis

Category Low Category High Category Average Category Mode
0.12 23.47 7.27 20.84